Vigabatrin-Associated Visual Field Defect — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Vigabatrin-associated visual field defect
Vigabatrin causes an irreversible concentric visual field defect in approximately 30–40% of patients on long-term therapy. It is due to retinal toxicity (GABA accumulation in retinal cells). The visual field loss is typically bilateral, concentric, and nasal-predominant, with preserved central acuity. Regular perimetric monitoring (every 6 months) is mandatory for all patients on vigabatrin. A: Glaucoma causes arcuate field defects, not concentric constriction. C: Optic neuritis causes central scotoma. D: RP causes ring scotoma with bone spicule pigmentation. E: Papilloedema causes enlarged blind spots.
Reference: NICE NG217 (2025); BNF – Vigabatrin; Vigabatrin SmPC